Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease

被引:25
作者
Blomqvist, MEL
Silburn, PA
Buchanan, DD
Andreasen, N
Blennow, K
Pedersen, NL
Brookes, AJ
Mellick, GD
Prince, JA
机构
[1] Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden
[2] Karolinska Inst, Dept Epidemiol & Biostat, Stockholm, Sweden
[3] Univ Gothenburg, Sahlgrens Univ Hosp, Dept Clin Neurosci & Transfus Med, Gothenburg, Sweden
[4] Huddinge Univ Hosp, Dept Geriatr Med, Stockholm, Sweden
[5] Univ Queensland, Sch Med, Princess Alexandra Hosp, Dept Neurol, Brisbane, Qld, Australia
关键词
IDE; age at onset; linkage disequilibrium; Alzheimer disease; Parkinson disease;
D O I
10.1007/s10048-004-0173-4
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We recently reported that a linkage disequilibrium (LD) block on chromosome 10q encompassing the gene encoding insulin-degrading enzyme (IDE) harbors sequence variants that associate with Alzheimer disease (AD). Evidence also indicated effects upon a number of quantitative indices of AD severity, including age-at-onset (AAO). Since linkage of this immediate region to AAO has been shown in both AD and Parkinson disease (PD), we have explored the possibility that polymorphism within this LD block might also influence PD. Utilizing single nucleotide polymorphisms that delineate common haplotypes from this region, we observed significant evidence of association with AAO in an Australian PD case-control sample. Analyses were complemented with AAO data from two independent Swedish AD case samples, for which previously reported findings were replicated. Results were consistent between AD and PD, suggesting the presence of equivalent detrimental and protective alleles. These data highlight a genomic region in the proximity of IDE that may contribute to AD and PD in a similar manner.
引用
收藏
页码:115 / 119
页数:5
相关论文
共 29 条
[1]   Cerebrospinal fluid β-amyloid(1-42) in Alzheimer disease -: Differences between early- and late-onset Alzheimer disease and stability during the course of disease [J].
Andreasen, N ;
Hesse, C ;
Davidsson, P ;
Minthon, L ;
Wallin, A ;
Winblad, B ;
Vanderstichele, H ;
Vanmechelen, E ;
Blennow, K .
ARCHIVES OF NEUROLOGY, 1999, 56 (06) :673-680
[2]   Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo [J].
Farris, W ;
Mansourian, S ;
Chang, Y ;
Lindsley, L ;
Eckman, EA ;
Frosch, MP ;
Eckman, CB ;
Tanzi, RE ;
Selkoe, DJ ;
Guénette, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :4162-4167
[3]  
GATZ M, 1997, J GERONTOL A-BIOL, V52, P117
[4]  
HARDY J, 2003, MOVEMENT DISORD, V18, P96
[5]   RISK-FACTORS FOR PARKINSONS-DISEASE [J].
HUBBLE, JP ;
CAO, T ;
HASSANEIN, RES ;
NEUBERGER, JS ;
KOLLER, WC .
NEUROLOGY, 1993, 43 (09) :1693-1697
[6]   Haplotype tagging for the identification of common disease genes [J].
Johnson, GCL ;
Esposito, L ;
Barratt, BJ ;
Smith, AN ;
Heward, J ;
Di Genova, G ;
Ueda, H ;
Cordell, HJ ;
Eaves, IA ;
Dudbridge, F ;
Twells, RCJ ;
Payne, F ;
Hughes, W ;
Nutland, S ;
Stevens, H ;
Carr, P ;
Tuomilehto-Wolf, E ;
Tuomilehto, J ;
Gough, SCL ;
Clayton, DG ;
Todd, JA .
NATURE GENETICS, 2001, 29 (02) :233-237
[7]   A full genome scan for late onset Alzheimer's disease [J].
Kehoe, P ;
Wavrant-De Vrieze, F ;
Crook, R ;
Wu, WS ;
Holmans, P ;
Fenton, I ;
Spurlock, G ;
Norton, N ;
Williams, H ;
Williams, N ;
Lovestone, S ;
Perez-Tur, J ;
Hutton, M ;
Chartier-Harlin, MC ;
Shears, S ;
Roehl, K ;
Booth, J ;
Van Voorst, W ;
Ramic, D ;
Williams, J ;
Goate, A ;
Hardy, J ;
Owen, MJ .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :237-245
[8]   Haplotypes extending across ACE are associated with Alzheimer's disease [J].
Kehoe, PG ;
Katzov, H ;
Feuk, L ;
Bennet, AM ;
Johansson, B ;
Wiman, B ;
de Faire, U ;
Cairns, NJ ;
Wilcock, GK ;
Brookes, AJ ;
Blennow, K ;
Prince, JA .
HUMAN MOLECULAR GENETICS, 2003, 12 (08) :859-867
[9]   Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease [J].
Kehoe, PG ;
Russ, C ;
McIlroy, S ;
Williams, H ;
Holmans, P ;
Holmes, C ;
Liolitsa, D ;
Vahidassr, D ;
Powell, J ;
McGleenon, B ;
Liddell, M ;
Plomin, R ;
Dynan, K ;
Williams, N ;
Neal, J ;
Cairns, NJ ;
Wilcock, G ;
Passmore, P ;
Lovestone, S ;
Williams, J ;
Owen, MJ .
NATURE GENETICS, 1999, 21 (01) :71-72
[10]   Age at onset in two common neurodegenerative diseases is genetically controlled [J].
Li, YJ ;
Scott, WK ;
Hedges, DJ ;
Zhang, FY ;
Gaskell, PC ;
Nance, MA ;
Watts, RL ;
Hubble, JP ;
Koller, WC ;
Pahwa, R ;
Stern, MB ;
Hiner, BC ;
Jankovic, J ;
Allen, AA ;
Goetz, CG ;
Mastaglia, F ;
Stajich, JM ;
Gibson, RA ;
Middleton, LT ;
Saunders, AM ;
Scott, BL ;
Small, GW ;
Nicodemus, KK ;
Reed, AD ;
Schmechel, DE ;
Welsh-Bohmer, KA ;
Conneally, PM ;
Roses, AD ;
Gilbert, JR ;
Vance, JM ;
Haines, JL ;
Pericak-Vance, MA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (04) :985-993